$FEAM
5E Advanced Materials, Inc.

2023 Q3 Form 10-K Financial Statement

#000095017023045509 Filed on August 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.038M $6.774M $25.37M
YoY Change 23.58% -33.04% -53.66%
% of Gross Profit
Research & Development $39.00K $1.860M $262.0K
YoY Change 0.0% -41.93% 96.99%
% of Gross Profit
Depreciation & Amortization $53.00K $92.00K $184.0K
YoY Change 43.24% -42.77% 64.29%
% of Gross Profit
Operating Expenses $7.713M $8.686M $36.71M
YoY Change -9.86% -34.96% -45.88%
Operating Profit -$7.713M -$36.71M
YoY Change -9.86% -45.88%
Interest Expense $1.787M -$1.578M $6.854M
YoY Change 117.66% -1800.8% 114133.33%
% of Operating Profit
Other Income/Expense, Net -$1.657M $12.00K $6.083M
YoY Change -112.59% -54.9% 444.1%
Pretax Income -$9.370M -$10.25M -$30.62M
YoY Change -303.43% -22.54% -54.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.370M -$10.25M -$30.62M
YoY Change -303.43% -22.54% -54.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.21 -$0.70
Diluted Earnings Per Share -$0.21 -$0.23 -$0.70
COMMON SHARES
Basic Shares Outstanding 44.22M 44.15M 43.84M
Diluted Shares Outstanding 44.22M 43.84M

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.80M $20.32M $20.32M
YoY Change -84.1% -34.56% -34.56%
Cash & Equivalents $11.80M $20.32M $20.32M
Short-Term Investments
Other Short-Term Assets $1.273M $1.808M $1.808M
YoY Change -16.96% 20.05% 20.05%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.07M $22.13M $22.13M
YoY Change -82.74% -32.04% -32.04%
LONG-TERM ASSETS
Property, Plant & Equipment $3.061M $3.056M $78.45M
YoY Change 7.52% 6.44% 110.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $314.0K $315.0K $315.0K
YoY Change -71.25% -71.15% -71.15%
Total Long-Term Assets $82.67M $78.77M $78.77M
YoY Change 80.02% 105.54% 105.54%
TOTAL ASSETS
Total Short-Term Assets $13.07M $22.13M $22.13M
Total Long-Term Assets $82.67M $78.77M $78.77M
Total Assets $95.74M $100.9M $100.9M
YoY Change -21.31% 42.34% 42.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.977M $1.492M $1.492M
YoY Change -58.05% -79.31% -56.87%
Accrued Expenses $7.206M $7.332M $7.332M
YoY Change 50.03% 4370.73% 4370.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $41.00K $40.00K $40.00K
YoY Change 5.13% 5.26% 5.26%
Total Short-Term Liabilities $9.224M $8.864M $8.864M
YoY Change -3.46% 20.17% 20.17%
LONG-TERM LIABILITIES
Long-Term Debt $63.66M $61.82M $37.67M
YoY Change 5.85% 41668.92% 25353.38%
Other Long-Term Liabilities $789.0K $798.0K $798.0K
YoY Change -93.23% 14.0% 14.0%
Total Long-Term Liabilities $63.66M $61.82M $38.47M
YoY Change 5.85% 41668.92% 4436.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.224M $8.864M $8.864M
Total Long-Term Liabilities $63.66M $61.82M $38.47M
Total Liabilities $50.98M $47.33M $47.33M
YoY Change -3.52% 475.55% 475.55%
SHAREHOLDERS EQUITY
Retained Earnings -$147.4M -$138.0M
YoY Change 43.4% 28.52%
Common Stock $442.0K $441.0K
YoY Change 1.84% 1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.76M $53.57M $53.57M
YoY Change
Total Liabilities & Shareholders Equity $95.74M $100.9M $100.9M
YoY Change -21.31% 42.34% 42.34%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$9.370M -$10.25M -$30.62M
YoY Change -303.43% -22.54% -54.1%
Depreciation, Depletion And Amortization $53.00K $92.00K $184.0K
YoY Change 43.24% -42.77% 64.29%
Cash From Operating Activities -$6.886M -$6.569M -$30.70M
YoY Change -11.85% 25.72% 7.27%
INVESTING ACTIVITIES
Capital Expenditures $51.00K $10.04M $352.0K
YoY Change 363.64% -247.93% -71.15%
Acquisitions
YoY Change
Other Investing Activities $776.0K $776.0K
YoY Change
Cash From Investing Activities -$1.631M -$9.269M -$39.31M
YoY Change -68.18% 36.5% 244.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K -9.000K 59.27M
YoY Change -100.02% -100.43% 93.55%
NET CHANGE
Cash From Operating Activities -6.886M -6.569M -30.70M
Cash From Investing Activities -1.631M -9.269M -39.31M
Cash From Financing Activities -10.00K -9.000K 59.27M
Net Change In Cash -8.527M -15.85M -10.73M
YoY Change -119.76% 59.66% 14.28%
FREE CASH FLOW
Cash From Operating Activities -$6.886M -$6.569M -$30.70M
Capital Expenditures $51.00K $10.04M $352.0K
Free Cash Flow -$6.937M -$16.61M -$31.05M
YoY Change -11.33% -1161.29% 4.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001888654
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41279
CY2023 dei Entity Registrant Name
EntityRegistrantName
5E ADVANCED MATERIALS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3426517
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
9329 Mariposa Road
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Hesperia
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92344
CY2023 dei City Area Code
CityAreaCode
442
CY2023 dei Local Phone Number
LocalPhoneNumber
221-0225
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023 dei Trading Symbol
TradingSymbol
FEAM
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
304400000
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44218406
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Denver, Colorado
CY2022 dei Auditor Name
AuditorName
BDO USA, LLP
CY2022 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20323000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31057000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1808000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1506000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
22131000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
32563000
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7637000
CY2022Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
8364000
CY2023Q2 feam Construction In Progress
ConstructionInProgress
67553000
CY2022Q2 feam Construction In Progress
ConstructionInProgress
25625000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3056000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2871000
CY2023Q2 feam Reclamation Bond Deposit
ReclamationBondDeposit
309000
CY2022Q2 feam Reclamation Bond Deposit
ReclamationBondDeposit
1086000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
207000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
371000
CY2023Q2 us-gaap Other Assets
OtherAssets
6000
CY2022Q2 us-gaap Other Assets
OtherAssets
6000
CY2023Q2 us-gaap Assets
Assets
100899000
CY2022Q2 us-gaap Assets
Assets
70886000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8728000
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7212000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
136000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
164000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8864000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7376000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
37671000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
148000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
211000
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
724000
CY2022Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
489000
CY2023Q2 us-gaap Liabilities
Liabilities
47333000
CY2022Q2 us-gaap Liabilities
Liabilities
8224000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44187000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43305000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
441000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
433000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
191113000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
169593000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137988000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107364000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53566000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
62662000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100899000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70886000
CY2023 feam Project Expenses
ProjectExpenses
9988000
CY2022 feam Project Expenses
ProjectExpenses
12902000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25365000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54684000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
262000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
133000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
908000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
184000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
112000
CY2023 us-gaap Operating Expenses
OperatingExpenses
36707000
CY2022 us-gaap Operating Expenses
OperatingExpenses
67831000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-36707000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-67831000
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
62000
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
65000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1147000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
11743000
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2023 us-gaap Interest Expense
InterestExpense
6854000
CY2022 us-gaap Interest Expense
InterestExpense
6000
CY2023 feam Other Non Operating Income Expense Excluding Other Income
OtherNonOperatingIncomeExpenseExcludingOtherIncome
-15000
CY2022 feam Other Non Operating Income Expense Excluding Other Income
OtherNonOperatingIncomeExpenseExcludingOtherIncome
1056000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6083000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1118000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30624000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66713000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-66713000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.7
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.7
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43842000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43842000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40807000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40807000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-66713000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1417000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30624000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68130000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
62329000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26309000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5222000
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31033000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
797000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6696000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-66713000
CY2022 feam Accumulated Other Comprehensive Income Loss
AccumulatedOtherComprehensiveIncomeLoss
-1417000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
62662000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3466000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-44000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4953000
CY2023 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
13153000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53566000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-66713000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
4953000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6696000
CY2023 feam Common Stock Issued For Consulting Fees
CommonStockIssuedForConsultingFees
0
CY2022 feam Common Stock Issued For Consulting Fees
CommonStockIssuedForConsultingFees
-31033000
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
11743000
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
908000
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
37000
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
9000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4907000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
164000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
125000
CY2023 feam Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
0
CY2022 feam Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
-1000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1056000
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
302000
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1347000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
821000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2533000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30695000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28615000
CY2023 feam Payments For Construction In Progress
PaymentsForConstructionInProgress
39731000
CY2022 feam Payments For Construction In Progress
PaymentsForConstructionInProgress
9994000
CY2023 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
0
CY2022 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
186000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
352000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1220000
CY2023 feam Payments For Reclamation Bonds
PaymentsForReclamationBonds
-776000
CY2022 feam Payments For Reclamation Bonds
PaymentsForReclamationBonds
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39307000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11400000
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
60000000
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4160000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
38000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
112000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26309000
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
797000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3466000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5222000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59268000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30622000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10734000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9393000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-361000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31057000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40811000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20323000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31057000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
7000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
6000
CY2023 feam Accounts Payable And Accrued Liabilities Change Related To Construction In Progress
AccountsPayableAndAccruedLiabilitiesChangeRelatedToConstructionInProgress
2197000
CY2022 feam Accounts Payable And Accrued Liabilities Change Related To Construction In Progress
AccountsPayableAndAccruedLiabilitiesChangeRelatedToConstructionInProgress
2922000
CY2023 feam Interest Paid Through Issuance Of Additional Convertible Notes
InterestPaidThroughIssuanceOfAdditionalConvertibleNotes
1710000
CY2022 feam Interest Paid Through Issuance Of Additional Convertible Notes
InterestPaidThroughIssuanceOfAdditionalConvertibleNotes
0
CY2023 feam Construction In Progress Transferred To Properties Plant And Equipment
ConstructionInProgressTransferredToPropertiesPlantAndEquipment
0
CY2022 feam Construction In Progress Transferred To Properties Plant And Equipment
ConstructionInProgressTransferredToPropertiesPlantAndEquipment
55000
CY2023 feam Equipment Acquired With Notes Payable
EquipmentAcquiredWithNotesPayable
0
CY2022 feam Equipment Acquired With Notes Payable
EquipmentAcquiredWithNotesPayable
206000
CY2023 feam Recognition Of Operating Lease Liabilities And Right Of Use Assets
RecognitionOfOperatingLeaseLiabilitiesAndRightOfUseAssets
0
CY2022 feam Recognition Of Operating Lease Liabilities And Right Of Use Assets
RecognitionOfOperatingLeaseLiabilitiesAndRightOfUseAssets
283000
CY2023 feam Increase Decrease In Asset Retirement Costs
IncreaseDecreaseInAssetRetirementCosts
198000
CY2022 feam Increase Decrease In Asset Retirement Costs
IncreaseDecreaseInAssetRetirementCosts
103000
CY2023 feam Business Combination Exchange Ratio Basis
BusinessCombinationExchangeRatioBasis
one for ten
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7637000
CY2022Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
8364000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
800000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.67
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1700000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain cash deposits at several major banks, which at times may exceed amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation (“FDIC”). We monitor the financial health of the banks and have not experienced any losses in such accounts and believe we are not exposed to any significant credit risk.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Items that are subject to such estimates and assumptions include, but are not limited to, estimated useful lives and valuation of properties, plant and equipment, mineral rights and properties, deferred tax assets, estimation of future costs, useful life, and discount rates used to calculate our asset retirement obligations (“ARO”), assumptions used to value the embedded conversion option of our convertible note, and fair value of stock-based compensation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023 us-gaap Lease Cost
LeaseCost
183000
CY2022 us-gaap Lease Cost
LeaseCost
182000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.39
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
835000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.15
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
148000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1904000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriod
-652000
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriodWeightedAverageExercisePrice
17.42
CY2023Q2 feam Reclamation Bond Deposit Current
ReclamationBondDepositCurrent
309000
CY2022Q2 feam Reclamation Bond Deposit Current
ReclamationBondDepositCurrent
1086000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.67
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5554000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.19
CY2023 feam Percentage Of Tax Benefit To Be Realized For Recognition In The Income Statement
PercentageOfTaxBenefitToBeRealizedForRecognitionInTheIncomeStatement
0.50
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain reclassifications have been made to prior years’ reported amounts in order to conform to the current year presentation. These reclassifications did not impact our previously reported net income (loss), stockholders’ equity or cash flows.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Mineral Properties Accumulated Impairment
MineralPropertiesAccumulatedImpairment
908000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
67553000
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
25625000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3374000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3022000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
318000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
151000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3056000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2871000
CY2023 us-gaap Depreciation
Depreciation
184000
CY2022 us-gaap Depreciation
Depreciation
112000
CY2022Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
489000
CY2021Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
377000
CY2023 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
31000
CY2022 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
106000
CY2023 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
167000
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-3000
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
37000
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
9000
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
724000
CY2022Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
489000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
168000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
124000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
168000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
125000
CY2023 us-gaap Short Term Lease Payments
ShortTermLeasePayments
15000
CY2022 us-gaap Short Term Lease Payments
ShortTermLeasePayments
57000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
15000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
57000
CY2023 feam Operating Lease Payments Including Short Term Lease Payments
OperatingLeasePaymentsIncludingShortTermLeasePayments
183000
CY2022 feam Operating Lease Payments Including Short Term Lease Payments
OperatingLeasePaymentsIncludingShortTermLeasePayments
181000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
140000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
74000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
214000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
210000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
136000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74000
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1492000
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3459000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1350000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1489000
CY2023Q2 feam Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
3386000
CY2022Q2 feam Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
1446000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1072000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
780000
CY2023Q2 feam Accrued Interest Current
AccruedInterestCurrent
1388000
CY2022Q2 feam Accrued Interest Current
AccruedInterestCurrent
0
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
40000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
38000
CY2023Q2 feam Accounts Payable And Accrued Liabilities Including Current Portion Of Long Term Debt
AccountsPayableAndAccruedLiabilitiesIncludingCurrentPortionOfLongTermDebt
8728000
CY2022Q2 feam Accounts Payable And Accrued Liabilities Including Current Portion Of Long Term Debt
AccountsPayableAndAccruedLiabilitiesIncludingCurrentPortionOfLongTermDebt
7212000
CY2023Q2 feam Capital Expenditure Included In Trade Accounts Payable
CapitalExpenditureIncludedInTradeAccountsPayable
699000
CY2022Q2 feam Capital Expenditure Included In Trade Accounts Payable
CapitalExpenditureIncludedInTradeAccountsPayable
1600000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
61858000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
186000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
40000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
38000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61818000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
148000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20691000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3456000
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
37671000
CY2023Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
40316000
CY2022Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
60000000
CY2023 feam Convertible Note Interest
ConvertibleNoteInterest
3098000
CY2022 feam Convertible Note Interest
ConvertibleNoteInterest
0
CY2023 feam Vehicle Notes Payable Interest
VehicleNotesPayableInterest
7000
CY2022 feam Vehicle Notes Payable Interest
VehicleNotesPayableInterest
6000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4907000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
CY2023 feam Gross Interest Expense
GrossInterestExpense
8012000
CY2022 feam Gross Interest Expense
GrossInterestExpense
6000
CY2023 feam Amount Capitalized To Construction In Progress
AmountCapitalizedToConstructionInProgress
1158000
CY2022 feam Amount Capitalized To Construction In Progress
AmountCapitalizedToConstructionInProgress
0
CY2023 us-gaap Interest Expense
InterestExpense
6854000
CY2022 us-gaap Interest Expense
InterestExpense
6000
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.2525
CY2022Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0
CY2022Q2 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
0
CY2023 feam Convertible Note Derivative Additions
ConvertibleNoteDerivativeAdditions
24896000
CY2023 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
11743000
CY2023 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
13153000
CY2023Q2 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
0
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
882000
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4900000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
797000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6200000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4874000
CY2022 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriod
-476000
CY2022 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriodWeightedAverageExercisePrice
5.48
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4187000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.91
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4874000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.67
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
3349000
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
9.82
CY2022 feam Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
3367000
CY2022 feam Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
7.3
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
838000
CY2023Q2 feam Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
15.23
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1507000
CY2022Q2 feam Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
6.05
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1507000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.05
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
270000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
5.79
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
800000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.11
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1700000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.26
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1177000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
5.88
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
463000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.65
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
292000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.26
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
838000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.42
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1507000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.05
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3349
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
9.82
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3367
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.3
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y1M6D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
24568000
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
206000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
128000
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
7300000
CY2023Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
5500000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30624000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-51234000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-15479000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30624000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66713000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30624000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66713000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6431000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14010000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1755000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2801000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
822000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-185000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-751000
CY2023 feam Income Tax Reconciliation Disallowed Exploration Costs
IncomeTaxReconciliationDisallowedExplorationCosts
0
CY2022 feam Income Tax Reconciliation Disallowed Exploration Costs
IncomeTaxReconciliationDisallowedExplorationCosts
-861000
CY2023 feam Income Tax Reconciliation Nondeductible Expense Interest On Convertible Note
IncomeTaxReconciliationNondeductibleExpenseInterestOnConvertibleNote
-649000
CY2022 feam Income Tax Reconciliation Nondeductible Expense Interest On Convertible Note
IncomeTaxReconciliationNondeductibleExpenseInterestOnConvertibleNote
0
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
1769000
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
0
CY2023 feam Income Tax Reconciliation Impact Of Change In Functional Currency
IncomeTaxReconciliationImpactOfChangeInFunctionalCurrency
-743000
CY2022 feam Income Tax Reconciliation Impact Of Change In Functional Currency
IncomeTaxReconciliationImpactOfChangeInFunctionalCurrency
0
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-256000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
97000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4584000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-16118000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18781000
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14282000
CY2023Q2 feam Deferred Tax Assets Amortization Of Exploration Expenditures
DeferredTaxAssetsAmortizationOfExplorationExpenditures
8437000
CY2022Q2 feam Deferred Tax Assets Amortization Of Exploration Expenditures
DeferredTaxAssetsAmortizationOfExplorationExpenditures
6423000
CY2023Q2 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
0
CY2022Q2 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
308000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2796000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1946000
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
740000
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
867000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30754000
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23826000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24791000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23671000
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5963000
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
155000
CY2023Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
5773000
CY2022Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
0
CY2023Q2 feam Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
33000
CY2022Q2 feam Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
53000
CY2023Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
157000
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
102000
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023 feam Operating Loss Carryforwards Expiration Period
OperatingLossCarryforwardsExpirationPeriod
P2037Y
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24800000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23700000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1120000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
15730000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2022 dei Auditor Firm
AuditorFirmId
243

Files In Submission

Name View Source Status
feam-20230630_lab.xml Edgar Link unprocessable
0000950170-23-045509-index-headers.html Edgar Link pending
0000950170-23-045509-index.html Edgar Link pending
0000950170-23-045509.txt Edgar Link pending
0000950170-23-045509-xbrl.zip Edgar Link pending
feam-20230630.htm Edgar Link pending
feam-20230630.xsd Edgar Link pending
feam-ex10_14.htm Edgar Link pending
feam-ex23_1.htm Edgar Link pending
feam-ex23_2.htm Edgar Link pending
feam-ex23_3.htm Edgar Link pending
feam-ex23_4.htm Edgar Link pending
feam-ex23_5.htm Edgar Link pending
feam-ex23_6.htm Edgar Link pending
feam-ex23_7.htm Edgar Link pending
feam-ex23_8.htm Edgar Link pending
feam-ex31_1.htm Edgar Link pending
feam-ex31_2.htm Edgar Link pending
feam-ex32_1.htm Edgar Link pending
feam-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img211599044_0.jpg Edgar Link pending
img211599044_1.jpg Edgar Link pending
img211599044_2.jpg Edgar Link pending
img211599044_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
feam-20230630_def.xml Edgar Link unprocessable
feam-20230630_cal.xml Edgar Link unprocessable
feam-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
feam-20230630_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending